The Global Fund goes into its pledging conference on Wednesday substantially short of its $18 billion minimum target to fight HIV/AIDS, tuberculosis and malaria over the next five years. Hosted by US President Joe Biden on the sidelines of the United Nations General Assembly (UNGA), the seventh replenishment conference is the culmination of a months-long […] Continue reading ->
As the push for adequate funds to address HIV, tuberculosis and malaria reaches its climax with next week’s replenishment meeting of the Global Fund, the fund’s latest report reveals it has saved 50 million lives between 2002 and 2021. The Global Fund raises money in three-year cycles and seeks $18 billion for its seventh replenishment, […] Continue reading ->
Two-fifths of people with tuberculosis are unaware that they are infected because their diagnosis relies on outdated tests – something Unitaid and partners aim to change with a $30 million investment in new diagnostic technologies to enable same-day results. Announcing the investment on Tuesday, the global health agency explained that the current diagnosis in low and […] Continue reading ->
Researchers have significantly strengthened the safety profile of a watershed treatment course for highly drug-resistant strains of tuberculosis — a heartening breakthrough set to change the lives of millions of MDR-TB patients around the world. The results of a randomized-controlled trial published in the New England Journal of Medicine today showed the new oral TB […] Continue reading ->
French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading ->